1. Introduction {#sec1}
===============

In many cells, the interplay of calcium (Ca^2+^) uptake and release processes results in oscillations in the intracellular Ca^2+^ concentration when surface receptors are stimulated by agonist \[[@bib1]\]. As diagrammed in [Figure 1](#fig1){ref-type="fig"}A, the binding of antigen-MHC (major histocompatibility complex) complexes to the T cell receptor (TCR) results in the activation of a tyrosine kinase that phosphorylates phospholipase C-gamma (PLC-γ) causing its activation. Activated PLC-γ cleaves phosphatidyl inositol (PIP~2~) in the plasma membrane into two parts, diacylglycerol (DAG) and inositol 1,4,5-triphosphate (IP~3~). The molecule DAG remains in the plasma membrane and activates protein kinase C (PKC). IP~3~, in contrast, is a diffusible cytosolic messenger, which binds to the IP~3~ receptor on the endoplasmic reticulum (ER) and synergistically with Ca^2+^ causes Ca^2+^ release from the ER. The ER is refilled by the sarcoplasmic and endoplasmic reticulum Ca^2+^-ATPases (SERCA) pump \[[@bib2]\]. In addition, there are also other membrane ion channels, voltage-dependent calcium (Cav1) and voltage- (Kv1.3) \[[@bib3],[@bib4]\] and calcium-dependent potassium channels (I~K(Ca),~ KCa3.1) \[[@bib4], [@bib5], [@bib6]\], that maintain the membrane potential \[[@bib7], [@bib8]\].Figure 1Schematic diagram for T cell activation and mechanism of IP~3~ activation. (A) Schematic diagram of the mechanism of Ca^2+^ dynamics in T-cells. (B) IP~3~ activation pathway. (C) The model of IP~3~R/channel subunit \[[@bib78]\]. Each subunit represents an IP~3~ binding site, activating and inactivating Ca^2+^ binding site. Each state is labeled X~ikj~, where i (IP~3~ binding site), j (activating Ca^2+^ binding site) and k (inactivating Ca^2+^ binding site) are equal to 0 (unoccupied binding site) or 1 (occupied binding site) \[[@bib78]\].Figure 1

Many studies have indicated that Ca^2+^ release-activated Ca^2+^ (CRAC) channels are responsible for Ca^2+^ influx, and that plasma membrane Ca^2+^-ATPases (PMCA) play a major role in removal of Ca^2+^ in T cells \[[@bib9]\]. In addition, mitochondria can modulate the Ca^2+^ influx by reducing the Ca^2+^-dependent inactivation of CRAC channels \[[@bib10]\]. The Ca^2+^ ion is a signaling molecule that binds to and activates the phosphatase calcineurin, which in turn binds to and dephosphorylates NFAT (nuclear factor -- activated T cells) \[[@bib11], [@bib12], [@bib13], [@bib14]\]. Dephosphorylation exposes nuclear localization signals on NFAT \[[@bib15]\], resulting in rapid translocation of the NFAT-calcineurin complex to the nucleus where it can participate in promoting gene transcription \[[@bib16]\]. In contrast to NFAT, NFκB is retained in the cytoplasm not by phosphorylation but by association with the inhibitory IκB protein \[[@bib17]\]. Increasing Ca^2+^ and activated PKCθ co-activate Iκ kinase (IKK) and phosphorylates IκB associated with NFκB allowing the IκB to dissociate from NFκB and marking the IκB for subsequent polyubiquitination and degradation by the proteasome \[[@bib18], [@bib19]\]. The free NFκB is translocated to the nucleus where it can bind to DNA and promote gene transcription. Moreover, in the related c-Jun NH~2~-terminal kinase (JNK) pathway, PKCθ mediates the activation of c-Jun ([Figure 1](#fig1){ref-type="fig"}A). PKC-θ is induced by co-stimulation of TCR/CD3 and CD28. Several studies show that PKCθ regulates the mitogen-activated protein kinase (MAP kinase) cascade, SEK1/MKK4 that directly phosphorylate JNK \[[@bib20], [@bib21]\]. Ca^2+^ activated calcineurin also activates on SEK1. Integration of these two activities reaches the full activation of JNK \[[@bib22]\]. As in result, activated JNK phosphorylates two positive regulatory serine residues in the activation domain of c-Jun. Finally, c-Jun and c-Fos protein together forms the activator-protein 1 (AP-1) transcription factors complex that participate in cell growth \[[@bib23]\].

Our previous model simulated the calcium clamp protocol used in the *in vitro* experiments used by Dolmetsch and co-workers; *in vivo*, however, the T cell has more complex calcium dynamics \[[@bib24], [@bib25]\]. The calcium dynamics model presented here explores how the interplay between Ca^2+^ influx through CRAC channels, the mitochondria, the plasmalemmal Ca^2+^-ATPase (PMCA) pump, and ER stores work together to control cytosolic calcium concentration (\[Ca^2+^\]~cyt~) dynamics and how membrane currents affect the calcium dynamics. This novel model includes the following features: 1) a mechanistic description of the cytosolic Ca^2+^ dynamics that relies on local Ca^2+^ signaling based on the experimental data of Bautista and co-workers \[[@bib26]\]; 2) IP~3~ production and degradation based on the work of Swillens and Mercan \[[@bib27]\]; 3) A novel description of the CRAC channel; 4) a description of the PMCA pump based on the experimental kinetics observed by Bautista and co-workers \[[@bib26]\]; 5) a description of the membrane potentials and the ion channels that regulate it 6) a voltage-dependent potassium channel (Kv1.3) based on the experimental data of Dupuis et al. \[[@bib28]\]; 7) a calcium-dependent potassium channel based upon the data of Verheugen et al. \[[@bib29]\]; 8) a description of the TRPM4 channel by Gaur et al. \[[@bib30]\]; 9) a new formulation of the TRPC3 channel based on the experimental data of Rose et al. \[[@bib31]\].; 10) the Cl^−^ channel based on data by Feske \[[@bib8]\] 11) the L-type Ca^2+^ channel description by Luo and Rudy \[[@bib32]\]; and a Na^+^ channel description by Luo and Rudy \[[@bib32]\].

Defects in the activation of NFAT and expression of IL-2 have been implicated in a number of human diseases and conditions. In several patients, failure to activate NFAT was shown to cause severe combined immunodeficiency disease, SCID \[[@bib8]\]. In contrast, a number of studies have suggested that active NFAT from patients infected by human immunodeficiency virus 1 (HIV-1) or human T-cell lymphotropic virus type-1 (HTLV-1) boost the viral infectivity \[[@bib33]\]. The NFAT pathway is also an important target for drugs such as FK506 and cyclosporine A, both powerful immunosuppressants that block the activation of calcineurin\'s phosphatase activity \[[@bib34], [@bib35], [@bib36]\]. While these drugs are useful for preventing the rejection of transplanted tissues, immune system suppression can lead to severe side effects, such as secondary tumors and opportunistic infections \[[@bib37]\], and progressive loss of renal function and neurotoxicity \[[@bib38]\]. In addition, inhibition of transcription factor activation in other types of cells can have unintended and undesirable consequences \[[@bib39]\].

A quantitative understanding of the mechanisms of T cell activation would help to predict the underlying mechanisms and suggest possible targets for drug intervention. Therefore, computational models are useful to understand the complex Ca^2+^ dynamics in transcription factors activation pathways both to find better ways to control the immune system in transplant patients and to find therapies for immunodeficiency viral infections.

2. Results {#sec2}
==========

Using the parameter values in Tables [1](#tbl1){ref-type="table"}, [2](#tbl2){ref-type="table"}, [3](#tbl3){ref-type="table"}, [4](#tbl4){ref-type="table"}, [5](#tbl5){ref-type="table"}, [6](#tbl6){ref-type="table"}, and [7](#tbl7){ref-type="table"}, the model under resting conditions reached steady state variable values shown in [Table 8](#tbl8){ref-type="table"}. After 1000 s at rest, the variable stay near the initial values with the membrane potential within the experimental range of 50--60 mV assuming the value of 59.0 mV at rest \[[@bib7], [@bib8]\]. Calcium concentrations for cytoplasmic (0.089 μM), endoplasmic (335.8 μM), and mitochondrial (0.00054 μM) calcium also fall within experimental ranges \[[@bib7], [@bib8], [@bib40]\].Table 1IP~3~ and DAG production and degradation parameters.Table 1ParametersDefinitionValuesReferencev~4~Maximal rate of IP~3~ and DAG formation by PLC5.0 μM s^−1^Scaled from \[[@bib27]\]v~5~Maximal rate of IP~3~ dephosphorylation12.5 μM s^−1^Scaled from \[[@bib27]\]v~6~Maximal rate of IP~3~ phosphorylation0.9 μM s^−1^Scaled from \[[@bib27]\]K~5~IP~3~ dissociation constant6.0 μMScaled from \[[@bib27]\]K~6~IP~3~ dissociation constant0.1 μMScaled from \[[@bib27]\]K~7~Ca^2+^ dissociation constant1.0 μMScaled from \[[@bib27]\]HHill coefficient1\[[@bib27]\]v~8~DAG degradation rate1.0 s^−1^EstimatedTable 2Ca^2+^ Regulatory Mechanism Parameters and Binding Constants of IP~3~ receptor.Table 2ParametersDefinitionValuesReferencev~1~Maximum IP~3~ receptor flux90 s^−1^Rescaled from \[[@bib78]\]a~1~IP~3~ binding constant400 μM^−1^ s^−1^\[[@bib78]\]a~2~Ca^2+^ inhibitory receptor binding constant0.2 μM^−1^ s^−1^\[[@bib78]\]a~3~IP~3~ binding constant400 μM^−1^ s^−1^\[[@bib78]\]a~4~Ca^2+^ Inhibitory receptor binding constant0.2 μM^−1^ s^−1^\[[@bib78]\]a~5~Ca^2+^activation receptor binding constant20.0 μM^−1^ s^−1^\[[@bib78]\]d~1~IP~3~ dissociation constant0.13 μM\[[@bib78]\]d~2~Ca^2+^ Inhibitory receptor dissociation constant1.049 μM\[[@bib78]\]d~3~IP~3~ dissociation constant0.9434 μM\[[@bib78]\]d~4~Ca^2+^ Inhibitory receptor dissociation constant0.1445 μM\[[@bib78]\]d~5~Ca^2+^activation receptor dissociation constant82.34 nM\[[@bib78]\]v~SERCA~Maximal velocity for SR Ca^2+^ ATPase1.0 μM s^−1^\[[@bib2], [@bib78]\]K~serca~Ca^2+^ dissociation constant for SR Ca^2+^ ATPase0.1 μM\[[@bib2], [@bib78]\]τ~sscyt~Transfer time constant between subspace and cytosol0.5 sEstimatedTable 3Ca^2+^ buffering parameters.Table 3ParametersDefinitionValuesReference\[B~s~\]~cyt~Total cytosolic stationary buffer concentration225.0 μM\[[@bib2]\]\[B~s~\]~ss~Total subspace stationary buffer concentration5.0 mM\[B~s~\]~ER~Total stationary buffer concentration in the ER2.0 mM\[[@bib2]\]\[B~e~\]~cyt~Total cytoplasmic buffer concentration in the cytosol111.0 μM\[[@bib2]\]\[B~e~\]~SS~Total buffer concentration in the subspace111.0 μMSame as \[B~e~\]~cyt~\[B~e~\]~ER~Total buffer concentration in the ER111.0 μMSame as \[B~e~\]~cyt~K~s~^ER^Stationary buffer dissociation constant in ER1.0 μM\[[@bib2]\]K~s~^cyt^Cytosolic stationary buffer dissociation constant for Ca^2+^0.1 μM\[[@bib2]\]K~s~^ss^Subspace stationary buffer dissociation constant for Ca^2+^0.1 μMSame as K~s~^cyt^K~e~^cyt^Mobile cytoplasmic buffer dissociation constant for Ca^2+^ in the cytosol0.123 μM\[[@bib26]\]K~e~^ss^Mobile buffer dissociation constant for Ca^2+^ in the subspace0.123 μMSame as K~e~^cyt^K~e~^ER^Mobile buffer dissociation constant for Ca^2+^ in the ER0.123 μMSame as K~e~^cyt^Table 4Parameters of mitochondrial dynamics.Table 4ParametersDefinitionValuesReferenceP~UNI~Uniporter Ca^2+^ permeability2.776× 10^−14^ s^−1^Estimatedα~m~Mitochondrial Ca^2+^ activity coefficient0.2\[[@bib89]\]α~ss~Subspace Ca^2+^ activity coefficient1.0Fit to \[[@bib26]\]V~nc~Na^+^-Ca^2+^ exchanger maximal velocity1.836 μM s^−1^EstimatedK~Na~Na^+^-Ca^2+^ exchanger Na + affinity8.0 mM\[[@bib90]\]K~Ca~Na^+^-Ca^2+^ exchanger Ca^2+^ affinity8 μM\[[@bib90]\]Ψ~m~Mitochondrial membrane potential160 mV\[[@bib91]\]\[Na^+^\]~SS~Extramitochondrial Na^+^ concentration5.0 mM\[[@bib32]\]\[Na^+^\]~m~Mitochondrial Na^+^ concentration5.0 mMEstimatedβ~Ca~Ca^2+^ buffers in the mitochondria.0.01\[[@bib92]\]Table 5Parameters of I~CRAC~ channel and PMCA pump.Table 5ParametersDefinitionValuesReferenceV~u~Unmodulated PMCA velocity1.54×10^6^ s^−1^\[[@bib26]\]K~u~Dissociation constant for Ca^2+^ stimulation of unmodulated PMCA303.0 nM\[[@bib26]\]V~m~Modulated PMCA velocity2.20×10^6^ s^−1^\[[@bib26]\]K~m~Dissociation constant for Ca^2+^ stimulation of modulated PMCA140.0 nM\[[@bib26]\]K~inact~Dissociation constant for ORAI1 Ca^2+^ inhibition by CRACR2A0.8 μMEstimatedK~cc~Dissociation constant for time constant for ORAI1 inhibition by calmodulin2.0 μMEstimatedK~act~Dissociation constant for ER Ca^2+^ inhibition200.0 μMEstimatedτ~inact~J~CRAC~ inactivation time constant40 s\[[@bib10]\]τ~act~J~CRAC~ activation time constant3 s\[[@bib93]\]α~SS~Subspace Ca^2+^ activity coefficient1.0Fit to \[[@bib26]\]α~o~Extracellular Ca^2+^ activity coefficient0.341Fit to \[[@bib26]\]P~CRAC~CRAC permeability to Ca^2+^2.8 × 10^−10^ cm^3^/sEstimatedTable 6General parameters.Table 6ParametersDefinitionValuesReferencezValence of Ca^2+^2Physical constantFFaraday\'s constant96484.6 coul (mol e^−^)^−1^Physical constantRIdeal gas constant8314 mJ mol^−1^ K^−1^Physical constantTAbsolute temperature310 KBody tempV~T~T cell volume2 pl\[[@bib26]\]V~cyt~Cytosol volume1.1 pl\[[@bib94]\]V~SS~Subspace volume0.11 pl\[[@bib94]\]V~ER~ER volume0.011 pl\[[@bib94]\]V~mito~Mitochondrial matrix volume0.088 pl\[[@bib94]\]Table 7--Membrane currents parameters.Table 7ParametersDefinitionValuesReferenceE~max~Maximum conductance for Ca^2+^-dependent K^+^ channel0.8 nS\[[@bib6], [@bib29]\]K~d~Ca^2+^ dissociation constant for Ca^2+^-dependent K^+^ channel0.45 μM\[[@bib29]\]g~t~Maximum conductance of the K^+^ channels3.0 nS\[[@bib6]\]E~K~Reversal potential of K^+^-84 mV\[[@bib6], [@bib95]\]g~Cl~Maximum conductance of the background current0.07 nSEstimatedE~Cl~Reversal potential for Cl^-^-33.0 mV\[[@bib95]\]g~Na~Maximum conductance of the Na + channels3.0 nSEstimatedE~Na~Reversal potential of K+-70 mV\[[@bib6], [@bib95]\]C~m~Membrane capacitance2.5e-3 nF\[[@bib94]\]E~Ca~Reversal potential of Ca^2+^60 mV\[[@bib6], [@bib95]\]PcaLL-type Ca^2+^ channel permeability0.3 x 10^−7^ cm^2^s^−1^\[[@bib32]\]g~TRPC3~Maximum conductance of TRPC3 channels0.00195 nSEstimatedK~DAG~DAG binding constant for TRPC3 activation2.0 μMEstimatedE~TRPM4~TRPM4 reversal potential0.2 mV\[[@bib30]\]g~TRPM4~Maximum conductance of TRPM4 channels1.2 nSEstimatedτ~xCa~Hodgkin-Huxley time constant TRPM4 channel30 s\[[@bib30]\]Table 8Steady-state values.Table 8VariablesInitial values\[Ca^2+^\]~cyt~0.089 μM\[Ca^2+^\]~ER~335.5 μM\[Ca^2+^\]~m~0.00054 μM\[Ca^2+^\]~ss~0.33 μMV-58.1 mV\[IP~3~\]~cyt~0.018 μM\[DAG\]0.050 μMX~100~0.039X~110~0.042X~000~0.27X~010~0.29X~001~0.17X~101~0.0033X~011~0.18X~111~0.0035u0.53m0.0898h0.0796n0.04j.08d0.00038f0.94x~Ca~0.0497JNK:PKC:Cn0.00398\[NFAT:P~i~\]~c~0.00957 μM\[NFAT:C∗\]~n~0.000723 μM\[NFκB\]~n~49.13 nM\[NFκB:IκB\]~c~31.69 nMinact0.90proact0.081

[Figure 2](#fig2){ref-type="fig"} presents simulations of cytosolic and endoplasmic reticulum calcium concentrations and fluxes. In these simulations, the extracellular calcium concentration (\[Ca^2+^\]~o~) was set to 2.0 mM from 420 s to 800 s and 0.0 mM otherwise. Increasing levels of agonist stimulation are assumed to result in increasing PLC activity in accordance with experimental studies on T cell receptor activation and PLC activity \[[@bib41]\]. The application of agonist (indicated by the gray bar in [Figure 2](#fig2){ref-type="fig"}A) is simulated by increasing the rate of IP~3~ production (and DAG) from PIP~2~ by phospholipase C (v~4~) from 0.05 μM s^−1^ to 5.0 μM s^−1^ after 64 s. The simulated traces for cytosolic \[IP~3~\] and \[DAG\] are shown in [Figure 3](#fig3){ref-type="fig"}. Simulated cytosolic calcium concentration is shown in [Figure 2](#fig2){ref-type="fig"}A. After the simulated application of agonist, there is a transient increase in \[Ca^2+^\]~cyt~.~.~ After the addition of 2.0 mM \[Ca^2+^\]~o~, a larger increase from baseline to a \~1.5 μM, followed by a slow decrease to a plateau of approximately 1.0 μM is observed. These results agree with the results observed by Bautista and co-workers \[[@bib26]\]. The time course of \[Ca^2+^\]~SS~ is similar to that of \[Ca^2+^\]~cyt~ except that the plateau of the second transient is larger in amplitude ([Figure 2](#fig2){ref-type="fig"}B). The cytosolic Ca^2+^ transients are accompanied by mitochondrial Ca^2+^ transients that are significantly larger in amplitude shown in [Figure 2](#fig2){ref-type="fig"}C. [Figure 2](#fig2){ref-type="fig"}D shows an initial depletion of \[Ca^2+^\]~ER~ as Ca^2+^ is released from the ER store in response to agonist. During the Ca^2+^ transients, the model predicts that PMCA switches from the unmodulated ([Figure 2](#fig2){ref-type="fig"}E; red line) to the modulated state ([Figure 2](#fig2){ref-type="fig"}E; black line) whenever \[Ca^2+^\]~cyt~ is elevated above the resting level.Figure 2Simulated Ca^2+^ transients with \[Ca^2+^\]~o~ = 2.0mM from 420s to 800s and agonist application after 60s. (A) The simulated cytosolic calcium concentration. (B) Subspace calcium transients are slightly higher than the cytosolic calcium concentration. (C) Mitochondrial Ca^2+^ concentration is higher than both \[Ca^2+^\]~cyt~ and \[Ca^2+^\]ss. (D) Initial intracellular ER store calcium concentration depletion as Ca^2+^ is released from the ER store, and an additional decrease in \[Ca^2+^\]~ER~ after removal of extracellular calcium. (E) A comparison of PMCA states corresponds to Ca^2+^ transient from unmodulated (red line) to modulated (black line) PMCA with \[Ca^2+^\]~o~ set to 2.0 mM from 420 s to 800 s.Figure 2Figure 3Simulated concentrations in T cell. (A) cytosolic IP~3~ and (B) DAG concentrations.Figure 3

[Figure 4](#fig4){ref-type="fig"} shows plasma membrane current responses in the simulations from [Figure 2](#fig2){ref-type="fig"}. As suggested by the Bautista, the model also predicts that the transient rise in cytosolic Ca^2+^ after the reintroduction of extracellular calcium is due to Ca^2+^ entry through the CRAC channel ([Figure 4](#fig4){ref-type="fig"}A). Ca^2+^ entry is accompanied by membrane hyperpolarization ([Figure 4](#fig4){ref-type="fig"}B), as observed by Tsien and co-workers \[[@bib42]\]. The depolarizing influence of the CRAC current is opposed by Ca^2+^ triggered opening K^+^ channels ([Figure 4](#fig4){ref-type="fig"}C) which contributes to hyperpolarization in [Figure 4](#fig4){ref-type="fig"}B, as well as by the opening of voltage-dependent K^+^ channels ([Figure 4](#fig4){ref-type="fig"}D). The TRPC3 channel opens in response to an increase in DAG to allow Ca^2+^ entry ([Figure 4](#fig4){ref-type="fig"}E). The TRPM4 channel conducts Na^+^ and K^+^ and is activated by Ca^2+^ ([Figure 4](#fig4){ref-type="fig"}F).Figure 4Simulated T cell membrane potential and major ionic currents. (A) Ca^2+^ release-activated Ca^2+^ (CRAC) current. (B) T cell membrane potential (C) Voltage-dependent K^+^ current (D) Ca^2+^-activated K^+^ current.Figure 4

Bautista and colleagues \[[@bib26]\] suggested that mechanisms of Ca^2+^ clearance from the cytosol include the PMCA, mitochondria, and SERCA. To investigate this proposal, four different simulations were performed with the model (Figures [5](#fig5){ref-type="fig"}, [6](#fig6){ref-type="fig"}, and [7](#fig7){ref-type="fig"}). The following protocol used by Bautista and colleagues was used for each of these simulations: \[Ca^2+^\]~o~ was set to 2.0 mM for 15 s and 40 s as indicated by the black bars above the graphs and held at 0.0 mM otherwise. Agonist was simulated by increasing the IP~3~ production rate from 0.01 μM s^−1^ to 5 μM s^−1^ after 64 s indicated by the gray bar. In their experiments, oligomycin/antimycin was added to block mitochondrial Ca^2+^ uptake to test the role of the mitochondria. To test the role of the ER, Ca^2+^ uptake was blocked by incubation with thapsigargin. Finally, both oligomycin/antimycin and thapsigargin were added to the incubation medium to simulate blocking of both mitochondrial and ER uptake of Ca^2+^.Figure 5Simulated the effects of mitochondria, PMCA, and SERCA on intracellular calcium clearance. (A) The first spike of Ca^2+^ was due to release of Ca^2+^ from the ER resulting mainly from opening of the IP~3~R, which was induced by the application of agonist. (B) The role of mitochondria is tested by blocking mitochondrial Ca^2+^ uptake. (C) The effects of the ER on Ca^2+^ clearance dynamics are determined by simulations with a disabled SERCA pump. (D) Both mitochondrial and ER uptake of Ca^2+^ are blocked by combining the protocols used in Figures. [4](#fig4){ref-type="fig"}B and 4C.Figure 5Figure 6Investigating the behavior of the Ca^2+^ fluxes through IP~3~ receptor and CRAC channel. (A) Ca^2+^ fluxes through the IP~3~ receptor from [Figure 4](#fig4){ref-type="fig"}: control (black), disabled mitochondrial Ca^2+^ uptake (red), blocked SERCA pump (green), and disabled mitochondria and SERCA (blue). (B) Ca^2+^ current for the four cases. (C) The activation of the CRAC channel is controlled by the \[Ca^2+^\]~ER~ for the four cases from [Figure 4](#fig4){ref-type="fig"}: control (black), disabled mitochondrial Ca^2+^ uptake (red dashed), blocked SERCA pump (green), and disabled mitochondria and SERCA (blue solid). (D) CRAC inactivation is driven by subspace Ca^2+^ concentration.Figure 6Figure 7The model predicts the Ca^2+^ concentrations in the ER, mitochondria, and subspace. (A) The changes in ER Ca^2+^ concentration for the four cases from [Figure 4](#fig4){ref-type="fig"}: control (black), disabled mitochondrial Ca^2+^ uptake (red), blocked SERCA pump (green), and disabled mitochondria and SERCA (blue). (B) The mitochondria activity for four cases. (C) The changes in subspace Ca^2+^ concentrations for all four cases.Figure 7

The control ([Figure 5](#fig5){ref-type="fig"}A) shows that after the addition of agonist there is an initial elevation of \[Ca^2+^\]~cyt~, followed by a second and a third cytosolic Ca^2+^ transient during the 15 s and 40 s intervals of raised \[Ca^2+^\]~o~. The next set of simulations tests the role of mitochondria by blocking mitochondrial Ca^2+^ uptake ([Figure 5](#fig5){ref-type="fig"}B). To simulate this hypothesis, the fluxes through the Ca^2+^ uniporter and mitochondrial membrane potential (Ψ~m~) were set to 0. As in the control, [Figure 5](#fig5){ref-type="fig"}A, 2.0 mM \[Ca^2+^\]~o~ was applied for 15 s and 40 s. In this case ([Figure 5](#fig5){ref-type="fig"}B), the first transient elevations of \[Ca^2+^\]~cyt~ are slightly higher than control ([Figure 5](#fig5){ref-type="fig"}A) and the third transient elevations of \[Ca^2+^\]~cyt~ are noticeably higher than control ([Figure 5](#fig5){ref-type="fig"}A). To determine the effects of the ER on Ca^2+^ clearance dynamics, simulations with a disabled SERCA pump (J~SERCA~ = 0) were performed ([Figure 5](#fig5){ref-type="fig"}C). In these simulations the initial \[Ca^2+^\]~cyt~ transient is mostly abolished and the third transient is slightly larger. Finally, when both mitochondrial and ER uptake of Ca^2+^ are blocked ([Figure 5](#fig5){ref-type="fig"}D) by combining the protocols used in Figures [5](#fig5){ref-type="fig"}B and 5C, the first transient is abolished, and the third transients are higher than the control. These results agree with the experimental observations \[[@bib26]\]. In all cases the second transients are slightly bigger than the control, also similar to experiments.

Studies have been shown that the main sources of Ca^2+^ that produce \[Ca^2+^\]~cyt~ transients in T lymphocytes are released from the ER through the IP~3~ receptor, and Ca^2+^ influx into the cell through the CRAC channel from the extracellular space \[[@bib9], [@bib43]\]. [Figure 6](#fig6){ref-type="fig"}A, B shows these Ca^2+^ currents for the four cases shown in [Figure 5](#fig5){ref-type="fig"}: control (black line), disabled mitochondrial Ca^2+^ uptake (red line), blocked SERCA pump (green line), and disabled both mitochondria and SERCA (blue line). The first transient after application of agonist is due entirely to release from the ER through the IP~3~ receptor ([Figure 6](#fig6){ref-type="fig"}A) for the control case (black solid line) and the case with blocked mitochondria (red). There is attenuated release from the ER in the cases with the SERCA blocked (green and blue lines overlapping). Release through the IP~3~ receptor contributes significantly to the second and third transient in all cases as the opening of CRAC channels provides Ca^2+^ to trigger Ca^2+^ release from the IP~3~ receptor, which is possible in the presence of IP~3~. There is a large CRAC current during both the second and third Ca^2+^ transients ([Figure 6](#fig6){ref-type="fig"}B). The behavior of the activation and inactivation "gates" for the CRAC channel which shown in [Figure 6](#fig6){ref-type="fig"}C, D. The activation of the CRAC channel is controlled by ER concentrations ([Figure 6](#fig6){ref-type="fig"}C). In the control case and case with the mitochondria blocked, the ER is full until application of agonist at which point the \[Ca^2+^\]~ER~ declines. When the ER is full the activation gate of the CRAC channel is near 0. When the ER depletes it rises to above 0.5. In the cases with the ER is blocked (green and blue lines), the activation gate of the CRAC channel starts the simulation partially activated and quickly rises for the duration of the simulation ([Figure 6](#fig6){ref-type="fig"}C). Note that in all cases for the second and third transients the CRAC activation gates are open, suggesting that activation of the CRAC channel is not responsible for the changes of I~CRAC~ seen in [Figure 6](#fig6){ref-type="fig"}B. [Figure 6](#fig6){ref-type="fig"}D shows the behavior of the CRAC inactivation by \[Ca^2+^\]~SS~. In all cases and with all transients, the CRAC activation gates are off at the beginning of the simulation (i.e. equal to 1). For the second transients, all cases are similar. However, for the third transients, CRAC currents are prolonged and slowly decrease. The downward deflections are inversely proportional to the transients in \[Ca^2+^\]~SS~. The inactivation gate of CRAC decreased in the four cases (arrow) with the probability described from largest decrease to the smallest decrease block of both SERCA and mitochondria (blue) \> being blocked mitochondria (red) \> blocked SERCA (green) \> control (black). This suggests that the differences in CRAC seen during this protocol are due to differences in CRAC inactivation governed by \[Ca^2+^\]~SS~.

To further understand the mechanisms at play, the model was used to predict the Ca^2+^ concentrations in the ER, mitochondria, and subspace. [Figure 6](#fig6){ref-type="fig"} shows all four cases with the same labeling scheme as [Figure 6](#fig6){ref-type="fig"}. After the application of agonist, the \[Ca^2+^\]~ER~ falls from its resting value of 335.5 μM ([Figure 7](#fig7){ref-type="fig"}A) for the control (black line) and the case with blocked mitochondria (red line) due to opening of the IP~3~ receptors (shown previously in [Figure 6](#fig6){ref-type="fig"}A). In the cases where the SERCA pump is blocked ([Figure 7](#fig7){ref-type="fig"}A -- green and blue lines overlapping) there is reduced \[Ca^2+^\] in the ER, at the start of the simulation. In these cases, the \[Ca^2+^\]~ER~ reaches is nadir of approximately 1 μM. During each of the \[Ca^2+^\]~cyt~ transients in the cases with functioning mitochondria ([Figure 7](#fig7){ref-type="fig"}B -- black solid and green lines) there is a transient rise in \[Ca^2+^\]~m~. When SERCA is blocked ([Figure 7](#fig7){ref-type="fig"}B -- green line), the \[Ca^2+^\]~m~ is smaller in amplitude transient and slightly lower during the first transient but otherwise similar to the control. This can be attributed to the decreased release from the ER seen in [Figure 6](#fig6){ref-type="fig"}A. In the cases with the mitochondria Ca^2+^ uptake blocked there is little notable change in \[Ca^2+^\]~m.~ From highest to lowest increases in the third transient, are the cases with both SERCA blocked (green) \> control (black) \> mitochondria and SERCA blocked (blue) \> blocked mitochondrial Ca^2+^ uptake (red). The changes in \[Ca^2+^\]~SS~ are shown in [Figure 7](#fig7){ref-type="fig"}C. When the SERCA is unblocked (black and red lines), the first transient is similar to the transients in \[Ca^2+^\]~cyt~. In the second and third transients, in all cases, there are transients in \[Ca^2+^\]~SS~. The difference in the cases is most clear in the third transient where there is prolonged Ca^2+^ entry through CRAC channels. Here the current, in order from highest to lowest (arrow), are the cases with both mitochondria and SERCA blocked (blue) \> blocked mitochondrial Ca^2+^ uptake (red) \> SERCA blocked (green) \> control (black) Note that these are opposite the contributions from CRAC inactivation by \[Ca^2+^\]~SS~ shown in the third transient in [Figure 6](#fig6){ref-type="fig"}D, indicating a possible role of CRAC channels in this observation.

The model was used to study the importance of I~CRAC~ for activation of NFAT, Ca^2+^ was triggered by the simulated application of agonist in the presence of 0.0 mM \[Ca^2+^\]~o~ to eliminate I~CRAC~ ([Figure 8](#fig8){ref-type="fig"}A). The result is an initial transient due to Ca^2+^ release from the ER followed by a return to baseline, and consequently little translocation of NFAT and NFκB (Figures [8](#fig8){ref-type="fig"}C and 8E, respectively) to the nucleus and little JNK activation ([Figure 8](#fig8){ref-type="fig"}G). In [Figure 8](#fig8){ref-type="fig"}B, \[Ca^2+^\]~o~ was set to 2.0 mM for 1000 s, and 0.0 mM after that. Agonist was added after 200 s. The \[Ca^2+^\]~cyt~ increases to peak of approximately 5 μM, then slowly decreases to a plateau of 1.0 μM. When \[Ca^2+^\]~o~ is reduced to 0.0 mM at 1200 s, the \[Ca^2+^\]~cyt~ decline back toward baseline. During the simulation protocol NFAT and NFκB (Figures [8](#fig8){ref-type="fig"}D and 8F, respectively) translocate to the nucleus during calcium transient and decline after the \[Ca^2+^\]~cyt~ decreases back to baseline [Figure 8](#fig8){ref-type="fig"}H shows the percent active JNK in the cytoplasm raises rapidly when PKCθ is activated and Ca^2+^ concentration increase. When Ca^2+^ are fall after 1200 s when agonist stimulation of PLC activation is ended i.e. production of IP~3~ returns to baseline), the JNK and NFAT levels fall rapidly and the NFκB declines more slowly. The simulated JNK and the experimental results from Leung and co-workers \[[@bib44]\] showing the co-activation by PKCθ and Ca^2+^ is greater than activation by either alone ([Figure 9](#fig9){ref-type="fig"}).Figure 8Transcription factors activation corresponds to the Ca^2+^ transient. (A) Transients in \[Ca^2+^\]~cyt~ are induced by agonist activation with 0.0 mM \[Ca^2+^\]~o~. Activation of NFAT from resting state corresponds to the top panel. (B) Simulation of Ca^2+^ transition in the cytoplasm (\[Ca^2+^\]~cyt~) is induced by agonist and \[Ca^2+^\]~ot~ was set to 2.0 mM for 1000 s. (C)--(D). Calculated active NFAT from the resting state corresponds to the Ca^2+^ transient from the top panels. (E)--(F) Simulated active ΝFκΒ from the resting state corresponds to the Ca^2+^ transient from the top panels. (G)--(H) Calculated percent active JNK from the resting state corresponds to the Ca^2+^ transient from the top panels.Figure 8Figure 9JNK Model. (A) Reaction dynamics of JNK. (B) Simulated JNK phosphorylation (activation). (C) Fold change of JNK phosphorylation compared to experiment (Avraham et. al., 1998 \[[@bib20]\]).Figure 9

The model was used to explore the role of the membrane currents in T lymphocyte activation. Experiments have shown that block of I~K~ (green)and I~K(Ca)~ (blue) can inhibit T lymphocyte activation \[[@bib45], [@bib46]\]. Their expression level differs across different types of T lymphocytes and knockdown experiments have shown that deficiency of I~K~ can be compensated for by I~K(Ca)~ \[[@bib47], [@bib48]\]. [Figure 8](#fig8){ref-type="fig"}AC shows that block of I~K(Ca)~ attenuates the Ca^2+^ transient and NFAT translocation to the nucleus. This is due to activation of I~K(Ca)~ during Ca^2+^ entry through the CRAC channel preventing membrane depolarization thereby maintaining the driving force for Ca^2+^ entry. Under the current parameter block of I~K~ has little effect on T lymphocyte activation. However, if I~K~ expression was increased so that it played a more significant role in preventing depolarization during Ca^2+^ entry, it would affect T lymphocyte activation.

In the current parameter set, L-type Ca^2+^ expression is low resulting in a small current ([Figure 10](#fig10){ref-type="fig"}A). As such it plays a small role in T lymphocyte activation as its block does little to alter the Ca^2+^ transient and NFAT translocation to the nucleus ([Figure 11](#fig11){ref-type="fig"}AC - tan). If the L-type current is increased and other currents rebalanced, its block can attenuate T lymphocyte activation. Block of I~Na~ shows little effect on T lymphocyte activation ([Figure 11](#fig11){ref-type="fig"}BD - pink). This is because I~Na~ activated during depolarization and not during the peak period of Ca^2+^ entry ([Figure 10](#fig10){ref-type="fig"}B).Figure 10Simulated T cell major ionic currents. (A) L-type Ca^2+^ current (B) Na^+^ current.Figure 10Figure 11Block of membrane currents can affect T lymphocyte activation. Agonist was applied from 200 s to 1200 s. \[Ca^2+^\]~o~ was held at 2,0 mM throughout the simulation. (A) \[Ca^2+^\]~cyt~ transients are reduced with block of I~K(Ca)~ (green) compared to control (black). Under the current channel expression levels, block of I~CaL~ (blue) and I~K~ (tan) have little effect on the \[Ca^2+^\]~cyt~ transient. (C) NFAT translocation to the nucleus is attenuated with block of I~K(Ca)~ (green) compared to control (black). Block of I~CaL~ (blue) and I~K~ (tan) have only a small effect on NFAT translocation to the nucleus. (B) \[Ca^2+^\]~cyt~ transients are reduced with block of I~TRPC3~ (dark green) compared to control (black). Under the current channel expression levels, block of I~TRPM4~ (light blue) and I~Na~ (fuschia) have little effect on the \[Ca^2+^\]~cyt~ transient. Note that increasing I~TRPM4~ decreases the \[Ca^2+^\]~cyt~ transient. (D) NFAT translocation to the nucleus is attenuated with block of I~TRPC3~ (dark green) compared to control (black). Block of I~Na~ (light blue) and I~TRPM4~ (fuchsia) have only a small effect on NFAT translocation to the nucleus.Figure 11

In model simulation, block of TRPM4 channels results in a slightly increased Ca^2+^ transient and increase in NFAT activation while increase expression of the channel results in a decreased Ca^2+^ transient and decrease in NFAT activation ([Figure 11](#fig11){ref-type="fig"}BD -- light blue). Increase in TRPM4 results in a decreased Ca^2+^ transient and NFAT (not shown). Experiments have shown that RNAi inhibition of TRPM4 in T cells results in an increase in the magnitude of the Ca^2+^ during activation \[[@bib49]\]. TRPM4 channels are activated by Ca^2+^ and the ensuing Na^+^ entry through open channels depolarizes the membrane reducing the driving force for Ca^2+^ through other channels such as CRAC \[[@bib50], [@bib51]\]. The model confirms this mechanism.

The model was used to explore the role of TRP channels in T lymphocyte activation. Block of TRPC3 attenuates Ca^2+^ entry, which limits NFAT translocation to the nucleus ([Figure 11](#fig11){ref-type="fig"}BD -- dark green). In the model, this is due to Ca^2+^ entry through TRPC3 during periods elevated DAG ([Figure 4](#fig4){ref-type="fig"}E and [Figure 3](#fig3){ref-type="fig"}). In experiments, TRPC3 mutants that had impaired channel function displayed smaller Ca^2+^ transients that T cells upon stimulation \[[@bib52]\]. Experiments show that TRPC3 channels contribute to Ca^2+^ entry and are activated by membrane bound DAG \[[@bib50], [@bib51]\].

Mutations in CRAC channel proteins have been identified in disease. Immunodeficiency 9 is caused by mutations in the ORAI1 and Immunodeficiency 10 is caused by mutation in STIM1 \[[@bib53]\]. Simulations show that block of ORAI1 (Ca^2+^ conductance set to zero) results greatly attenuates Ca^2+^ transient (due to block Ca^2+^ entry) and NFAT translocation to the nucleus ([Figure 12](#fig12){ref-type="fig"}AB -- red). If the ER Ca^2+^ sensing function is removed, i.e.$\left\lbrack {Ca^{2 +}} \right\rbrack_{ER}^{4.7} = 330$ in $act_{\infty} = \frac{K_{act}^{4.7}}{K_{act}^{4.7} + \left\lbrack {Ca^{2 +}} \right\rbrack_{ER}^{4.7}}$, the Ca^2+^ transient and NFAT translocation is greatly attenuated as CRAC is not activated ([Figure 12](#fig12){ref-type="fig"}AB -- green). STIM1 oligomerization is considered to necessary for activation of CRAC because it thought to be a prerequisite for activation of ORAI1. In the model if the oligomerization is removed by setting the Hill coefficient to n = 1 (instead of n = 4.7) in the equation for ER Ca^2+^ sensing, activation actually occurs earlier as there is a more gradual response (the Hill curve is not as steep) as seen in [Figure 12](#fig12){ref-type="fig"}AB -- blue. This agrees with the idea that the oligomerization must be a part of the process of ORAI1 activation.Figure 12Blocking STIM1 and ORAI greatly attenuate T lymphocyte activation. Agonist was applied from 200 s to 1200 s. \[Ca^2+^\]~o~ was held at 2,0 mM throughout the simulation. (A) Block of the channel conductance of ORAI1 (red) or blocking the Ca^2+^ sensitivity of STIM1 (green) greatly attenuate the \[Ca^2+^\]~cyt~ transient compared to control (black). Blocking the cooperativity of STIM1 (blue) but still allowing monomers to activate ORAI1 has little effect the \[Ca^2+^\]~cyt~ transient. (B) Block of the channel conductance of ORAI1 (red) or blocking the Ca^2+^ sensitivity of STIM1 (green) greatly attenuate NFAT translocation to the nucleus compared to control (black). Blocking the cooperativity of STIM1 (blue) but still allowing monomers to activate ORAI1 has little effect on NFAT translocation to the nucleus.Figure 12

Experimental studies have suggested that Ca^2+^ uptake by mitochondria is necessary for CRAC activation and that in the absence of mitochondrial Ca^2+^ uptake, the CRAC channel inactivates \[[@bib54]\]. Experiments have shown that blocking either mitochondrial calcium uptake via the Ca^2+^ uniport (J~uni~) or blocking the mitochondrial Na^+^-Ca^2+^ exchanger (J~nc~) result in reduced Ca^2+^ entry through CRAC channels \[[@bib7]\]. There have been various hypotheses about to the mechanism behind this phenomenon. 1) The mitochondrial uptake Ca^2+^ preventing Ca^2+^-inactivation of CRAC \[[@bib10]\]; 2) STIM1 oligomerization is considered to necessary for activation of CRAC. Experiments show that if mitochondrial Ca^2+^ uptake is blocked by either bock of the mitochondrial Ca^2+^ uniporter or through loss of membrane potential through uncoupling STIM1 oligomerzation is inhibited \[[@bib55]\]. 3) Ca^2+^ bound calmodulin has been show to bind to STIM1 and ORAI1 leading to inactivation of the channel and disassociation of the STIM1 oligomer \[[@bib56], [@bib57]\]. 4) Block of J~nc~ results in mitochondrial Ca^2+^ overload and excess ROS production which leads to oxidation of ORAI1 inactivating Ca^2+^ entry through CRAC \[[@bib58]\].

Model simulations were performed to explore how different mitochondrial might play a role in inactivation of the CRAC channel. Block of the mitochondrial Ca^2+^ uniporter results in a larger calcium transient ([Figure 13](#fig13){ref-type="fig"} -- red). The model suggests that this increase in Ca^2+^ due to the loss of the buffering of Ca^2+^ provided by the mitochondria. The CRAC channel current is inhibited over control ([Figure 13](#fig13){ref-type="fig"}C -- red vs black). Blocking inactivation of the CRAC channel by Ca^2+^ results in a large increase in the Ca^2+^ channel and CRAC current suggesting that this plays a major role in controlling Ca^2+^ entry ([Figure 13](#fig13){ref-type="fig"} -- blue). In our model, this effect is assumed to be conferred by Ca^2+^ binding to CRACR2A. Calmodulin has also been shown to affect conductance through ORAI1. We modeled this effect as regulating the rate at which the channel inactivated ([Figure 13](#fig13){ref-type="fig"} -- green). This also has a large effect on CRAC current. However, none of these resulting in significant inhibition of CRAC current and loss of NFAT translocation to the nucleus. In the model all these processes to inactivate CRAC are reversible. This analysis suggests that there must be an inactivation process, not explicitly modeled from which there is slow return from the inactivated state. When such a process is included, it is possible to get mitochondrial inhibition resulting in a reduction of NFAT activation. However, such a mechanism is not presented as the mechanism is not clear.Figure 13The role of mitochondrial Ca^2+^ uptake on T lymphocyte activation. Agonist was applied from 200 s to 1200 s. \[Ca^2+^\]~o~ was held at 2,0 mM throughout the simulation. (A) Block of the channel conductance of the mitochondrial Ca^2+^ uniporter (red) slightly increases the \[Ca^2+^\]~cyt~ transient compared to control (black). Blocking the Ca^2+^-dependent inhibition of ORAI1 (blue) or blocking the Ca^2+^-dependent rate of inhibition (green) result in a large \[Ca^2+^\]~cyt~ transient. (B) Block of the channel conductance of the mitochondrial Ca^2+^ uniporter (red) slightly decreases NFAT translocation to the nucleus compared to control (black). Blocking the Ca^2+^-dependent inhibition of ORAI1 (blue) or blocking the Ca^2+^-dependent rate of inhibition (green) increases NFAT translocation to the nucleus. (C) Block of the channel conductance of the mitochondrial Ca^2+^ uniporter (red) slightly decreases CRAC current compared to control (black). Blocking the Ca^2+^-dependent inhibition of ORAI1 (blue) or blocking the Ca^2+^-dependent rate of inhibition (green) result in increased CRAC current.Figure 13

3. Discussion {#sec3}
=============

We have developed a mathematical model for calcium dynamics in T lymphocytes induced by IP~3~ to mimic T cell activation by antigen. Our model includes intracellular calcium signaling dynamics, transcription factor signaling, intracellular signaling cascades, and plasma membrane ion channels and pumps. The model reproduces several experimentally observed behaviors of Ca^2+^ signaling pathways in T cells. The \[Ca^2+^\]~cyt~ simulation results closely match the experimental data of Bautista and co-workers \[[@bib26]\]. Calcium influx prolongs the calcium transient in the cytoplasm, and the PMCA pump plays the leading role in cytosolic Ca^2+^ clearance from the cell. This work shows that the SERCA pump and mitochondria together have an impact on the rate of Ca^2+^ extrusion. The model also explores the contributions of mitochondria dynamics and I~CRAC~ to activation of NFAT. Experimental studies indicated that mitochondria localized close to the cell membrane absorb calcium from I~CRAC~ \[[@bib9], [@bib10]\], suggesting that increases in local \[Ca^2+^\]~cyt~ leads to inactivation of I~CRAC.~ The model explores this hypothesis and assumes a local subspace contains mitochondria near the CRAC channel. In order to further validate the predictive value of the model, simulation results are compared to experimental data that was not used to constrain the model. In particular, the time course of \[Ca^2+^\]~SS~ and \[Ca^2+^\]~m~ from [Figure 2](#fig2){ref-type="fig"}B, C compares well to the experimental data. The significant rise in \[Ca^2+^\]~m~ close to the site of Ca^2+^ entry is similar to that shown in Schwindling et al (2010) \[[@bib59]\]. The model predictions about \[Ca^2+^\]~SS~ and plasmalemmal Ca^2+^ ATPase currents are similar to the experimental results of Quintana et al 2011 \[[@bib60]\].

We have also tested the role of the voltage-dependent sodium (Nav1.5) that is only present in a small fraction of cells \[[@bib61]\]. To this end, a voltage-dependent sodium channels based on the experimentally verified Luo-Rudy model \[[@bib32]\] was also included to test its possible role in T cell activation. The currents generated by this channel were small and sensitivity analysis showed no significant effect of Na^+^ channel conductance on NFAT translocation into the nucleus.

In this paper, our simulations suggest that NFAT and NFκB activation can be inhibited by decreasing \[Ca^2+^\]~cyt~ through termination of Ca^2+^ release from the ER and thus preventing opening of CRAC channels. This finding suggests that blocking I~CRAC~ might be a possible target for immunosuppression. The exact mechanism of opening of CRAC channels is still not clear. One hypothesis is that ER stores reside close to CRAC channels \[[@bib9]\] and there is some sort of physical sensor that transmits ER depletion to the CRAC channel. Many studies showed that Ca^2+^ influx has a great impact on T-cell activation and proliferation \[[@bib9], [@bib33]\]. Our model suggests that Ca^2+^ entry from CRAC channels is essential for NFAT and NFκB activity. The model can also be used to understand other mutations leading to T lymphocyte dysfunction. Mutations in the Gimap5 gene lead the immune system disorders through T cell dysfunction \[[@bib62]\]. Gimap5 inhibits a protein that inactivates GSK3, there the mutation leads to increased GSK3 activity \[[@bib62]\]. Our previous studies have shown that GSK3 dephosphorylates nuclear NFAT allowing it to be translocated out of the nucleus \[[@bib63]\]. The model predicts that the Gimap5 mutation might lead to immune dysfunction by increasing NFAT export from the nucleus. Mutations in the IP~3~R can lead to T cell lymphoma with some mutants contributing to increased IP~3~R Ca^2+^ release while others lead to increased IP~3~ sensitivity with no observed change to Ca^2+^ dynamics \[[@bib64]\]. Our previous work in Ca^2+^ dynamics in cardiac myocytes offers and explanation \[[@bib65], [@bib66]\]. With increased IP~3~R open probability, there is Ca^2+^ efflux (leak) from the ER. This results in lower ER Ca^2+^ content reducing the driving force for Ca^2+^ efflux during IP~3~R opening. The production of increased open probability and decreased driving force returns the Ca^2+^ transient to normal levels.

Our model successfully simulates the calcium dynamics and control of NFAT and NFκB activation. However, not every feature present in the T cell could be represented, only selected ones. There are many improvements to the model possible to address important scientific questions, including upstream elements of the signaling pathway, the role mitochondrial function, cytoskeleton, spatial reorganization, and changes in gene expression play in T cell physiology.

Upstream elements of the T cell activation signaling pathway can be added to the model, for example, the activation of DAG and protein kinase C (PKC) on calcium and its feedback on phospholipase C (PLC). The early events in T cell activation show that IP~3~ induction of Ca^2+^ release from ER stores follows the cleavage of PIP~2~ by PLCγ1, and suggest that this time delay in the activation of PLCγ1 could account for the experimentally observed a delay in calcium signaling \[[@bib67]\].

Calcium signaling between the mitochondria and ER plays a role in T cell physiological processes such as activation, effector functions, lineage determination, apoptosis, autophagy and mitochondrial bioenergetics \[[@bib68], [@bib69], [@bib70], [@bib71]\]. It has been suggest that mitochondrial contact sites are necessary for the reprogramming and stimulation of energy metabolism that occurs during T cell activation \[[@bib69]\]. In its current form, the model cannot address these issues. We understand that the role mitochondria play in T cell activation is topic of current research and hope to include that in future work. We have a detailed model of ionic homeostasis and energy metabolism that we developed for the cardiac myocyte that demonstrates activation of energy metabolism. It is clear that increases in mitochondrial Ca^2+^ can stimulate energy production, but changes in ADP, ATP, and NADH levels can also contribute to meeting the increased energy demands during T cell activation. There is also experimental evidence that NFAT activation triggers signaling cascades that also increase energy production in the T cell \[[@bib14]\]. The model currently does not address these issues, but lays the foundations for future modeling. This model described membrane ion channels, calcium dynamics and transcription factor signaling during T cell activation. While we have not modeled apoptosis, and autophagy, there are models that have been developed to describe these processes that might be adapted for this purpose. In future work, we hope to add features to this model for the T cell and explore these issues.

The changes to spatial organization, membrane ultrastucture, and signaling pathways and changes to gene expression are crucial to T cell activation and other physiological processes \[[@bib72], [@bib73]\]. This suggests that the development of a spatial model might be helpful in understanding T cell physiology. For example, the STIM1:ORAI1 puncti that form during T cell activation display single channel ORAI responses with complex dynamics. Describing these might require development of a spatial stochastic model \[[@bib74]\]. Different types of T cells have different ion channel expression. The model in the future could be used to explore these cell-to-cell differences.

NFAT activation resulting from Ca^2+^ mobilization is important for the differentiation into T helper 1 (Th1), Th2, Th17, regulatory T (Treg), and follicular helper T cells (Tfh) through interaction with different other transcription factors such as GATA3 and Foxp3 \[[@bib75]\]. Another future question that can be addressed by the model is the differentiation of T cells after activation requires activation of different transcription factors. This might arise different patterns of signaling that might arise from cell heterogeneity.

During T cell activation there is a reorganization of cellular structure to form the immunological synapse \[[@bib76]\]. These changes rely on the microtubular network and actin cytoskeleton. Movement of the cytoskeleton responds to Ca^2+^ mobilization \[[@bib72]\]. There has been significant computational modeling studies on how the cytoskeleton reorganizes cell structure, for example, in dendritic spines, that can be used in future work to understand these dynamics \[[@bib77]\].

4. Materials and methods {#sec4}
========================

4.1. The model {#sec4.1}
--------------

The De Young-Keizer model \[[@bib78]\] was revised to include four different Ca^2+^ compartments, the ER, the cytosol, the mitochondria, and a subspace between the plasma membrane and mitochondria. The model describes the membrane potential and several ion channels that regulate it. The model also includes the Ca^2+^ release-activated Ca^2+^ (CRAC) channel (STIM1, ORAI1, and CRACR2A), the plasmalemmal Ca^2+^-ATPase (PMCA), and the dynamics of IP~3~ production and degradation. The model consists differential equations describing the time rate of change of the following quantities: (1) the ER Ca^2+^ concentration (\[Ca^2+^\]~ER~); (2) the cytosolic IP~3~ concentration (\[IP~3~\]~cyt~); (3) the eight states of IP~3~R gating; (4) the mitochondrial Ca^2+^ concentration (\[Ca^2+^\]~m~); (5) the subspace Ca^2+^ concentration (\[Ca^2+^\]~SS~); (6) the fraction of PMCA channels in the unmodulated state (u); (7) the cytosolic Ca^2+^ concentration (\[Ca^2+^\]~cyt~); (8) the three gates of the sodium channel (I~Na~); (9) the voltage dependent K^+^ channel (I~K~); (10) the calcium activated potassium channel I~K(Ca)~; (11) the L-type Ca^2+^ current; (12) the TRPM4 current (I~TRPM4~); (13) the TRPC3 current (I~TRPC3~); (14) the membrane potential (V). The parameter values and definitions are given in Tables [1](#tbl1){ref-type="table"}, [2](#tbl2){ref-type="table"}, [3](#tbl3){ref-type="table"}, [4](#tbl4){ref-type="table"}, [5](#tbl5){ref-type="table"}, [6](#tbl6){ref-type="table"}, [7](#tbl7){ref-type="table"}, [8](#tbl8){ref-type="table"}, and [9](#tbl9){ref-type="table"}. Changes to the parameters for a particular simulation are stated in the text where the simulations are described. Model Fortran code is included as supplementary material. Sensitivity analysis was also performed to ensure that the model was not overly sensitive to any model parameters ([Figure 14](#fig14){ref-type="fig"}).Table 9JNK activation rate constants.Table 9Rate ConstantValuek~1~0.016k~2~0.00038k~3~0.00012k~4~0.0075k~5~0.00001k~6~0.00088k~7~0.00001k~8~0.00025Figure 14Sensitivity analysis for NFAT activation depended upon model parameters.Figure 14

The ER store dynamics are governed by four processes: (1) Ca^2+^ buffering (β~ER~), (2) Ca^2+^ sequestration in the ER though the sarcoplasmic reticulum calcium ATPase (J~SERCA~) from the cytosol, and (3) Ca^2+^ release from the ER through the IP~3~ receptor (J~IP3R~). The balance equation for \[Ca^2+^\]~ER~ is$$\frac{d\left\lbrack Ca^{2 +} \right\rbrack_{ER}}{dt} = \beta_{ER}\left( \frac{J_{SERCA} - J_{IP_{3}R}}{V_{ER}/V_{cyt}} \right)$$where β~ER~ represents the fractional buffering of Ca^2+^ in the ER using the rapid buffering approximation developed by Wagner and Keizer \[[@bib79]\] described as follows:$$\beta_{ER} = \left\{ {1 + \frac{\left\lbrack B_{S}^{ER} \right\rbrack_{ER}K_{S}^{ER}}{\left( K_{S}^{ER}+\left. \left\lbrack Ca^{2 +} \right\rbrack_{ER} \right)^{2} \right.} + \frac{\left\lbrack B_{e}^{ER} \right\rbrack K_{e}^{ER}}{\left( K_{e}^{ER}\left. + \left\lbrack Ca^{2 +} \right\rbrack_{ER} \right)^{2} \right.}} \right\}^{- 1}$$where $\left\lbrack B_{S}^{ER} \right\rbrack_{ER}$ is the total concentration of stationary buffer in the ER, and other rate constants are defined as shown in [Table 3](#tbl3){ref-type="table"}.

The SERCA flux for Ca^2+^ movement from the cytoplasm into the ER, (J~SERCA~) is described by$$J_{SERCA} = \frac{v_{SERCA}\left\lbrack {Ca^{3 +}} \right\rbrack_{ER}^{2}}{\left\lbrack {Ca^{3 +}} \right\rbrack_{ER}^{2} + K_{SERCA}^{2}}$$where K~SERCA~ is the binding constant for Ca^2+^ to the pump.

The flux of Ca^2+^ through the IP~3~ receptor (J~IP3R~) into the cytosol can be described by$$J_{IP_{3}R} = \frac{V_{ER}}{V_{cyt}}v_{1}X_{110}^{3}\left( \left\lbrack Ca^{2 +} \right\rbrack_{ER} - \left\lbrack Ca^{2 +} \right\rbrack_{cyt} \right)$$where v~1~ is the maximal Ca^2+^ flux rate through the IP~3~R, and X~110~ is the fraction of IP~3~R subunits in the open state. The ER and cytosolic Ca^2+^ concentrations are represented by \[Ca^2+^\]~ER~ and \[Ca^2+^\]~cyt~, respectively, and their difference describes the Ca^2+^ concentration gradient.

The notation X~110~ comes from the model of the IP~3~ receptor developed by De Young and Keizer and denotes that IP~3~ has already bound a channel subunit (1 in the first subscript position), but activating Ca^2+^ is bound (1 in the second subscript position) but no inactivating Ca^2+^ is bound (0 in the third subscript position has yet bound so the channel is open) ([Figure 1](#fig1){ref-type="fig"}C) \[[@bib78]\]. The channel state X~110~ is cubed to fit the experimental data and suggests that three subunits must be in this state for the channel to conduct Ca^2+^. The rate constants are defined as shown in [Table 2](#tbl2){ref-type="table"}. The equations for activation and inactivation states of cytosolic IP~3~ receptors by Ca^2+^ are describing in the following equations:$$f_{1} = b_{5}X_{010} - a_{5}\left\lbrack Ca^{2 +} \right\rbrack_{cyt}X_{000}$$$$f_{2} = b_{1}X_{100} - a_{1}\left\lbrack IP_{3} \right\rbrack_{cyt}X_{000}$$$$f_{3} = b_{4}X_{001} - a_{4}\left\lbrack Ca^{2 +} \right\rbrack_{cyt}X_{000}$$$$f_{4} = b_{5}X_{110} - a_{5}\left\lbrack Ca^{2 +} \right\rbrack_{cyt}X_{100}$$$$f_{5} = b_{2}X_{101} - a_{2}\left\lbrack Ca^{2 +} \right\rbrack_{cyt}X_{100}$$$$f_{6} = b_{1}X_{110} - a_{2}\left\lbrack IP_{3} \right\rbrack_{cyt}X_{010}$$$$f_{7} = b_{4}X_{011} - a_{4}\left\lbrack Ca^{2 +} \right\rbrack_{cyt}X_{010}$$$$f_{8} = b_{5}X_{011} - a_{5}\left\lbrack Ca^{2 +} \right\rbrack_{cyt}X_{001}$$$$f_{9} = b_{3}X_{101} - a_{3}\left\lbrack IP_{3} \right\rbrack_{cyt}X_{001}$$$$f_{10} = b_{2}X_{111} - a_{2}\left\lbrack Ca^{2 +} \right\rbrack_{cyt}X_{110}$$$$f_{11} = b_{5}X_{111} - a_{5}\left\lbrack Ca^{2 +} \right\rbrack_{cyt}X_{101}$$$$f_{12} = b_{3}X_{111} - a_{3}\left\lbrack IP_{3} \right\rbrack_{cyt}X_{011}$$$$\frac{dX_{000}}{dt} = f_{1} + f_{2} + f_{3}$$$$\frac{dX_{100}}{dt} = f_{4} + f_{5} - f_{2}$$$$\frac{dX_{010}}{dt} = - f_{1} + f_{6} + f_{7}$$$$\frac{dX_{001}}{dt} = f_{8} - f_{3} + f_{9}$$$$\frac{dX_{110}}{dt} = - f_{4} - f_{6} + f_{10}$$$$\frac{dX_{101}}{dt} = f_{11} - f_{9} - f_{5}$$$$\frac{dX_{011}}{dt} = - f_{8} - f_{7} + f_{12}$$$$\frac{dX_{111}}{dt} = - f_{11} - f_{12} - f_{10}$$

The IP~3~ production and degradation dynamics in the cytosol are based on the Swillens-Mercan model \[[@bib27]\]. The equation of free cytosolic concentration of IP~3~ (\[IP~3~\]~cyt~) is given by$$\frac{d\left\lbrack IP_{3} \right\rbrack_{cyt}}{dt} = v_{4} - \frac{v_{5}}{\left\lbrack {1 + \left( \frac{K_{5}}{\left\lbrack IP_{3} \right\rbrack_{cyt}} \right)^{h}} \right\rbrack} - \frac{v_{6}}{\left\lbrack {1 + \left( \frac{K_{6}}{\left\lbrack IP_{3} \right\rbrack_{cyt}} \right)^{h}} \right\rbrack}\frac{1}{\left\lbrack {1 + \left( \frac{K_{7}}{\left\lbrack Ca^{2 +} \right\rbrack_{cyt}} \right)} \right\rbrack}$$where v~4~ is the rate of formation of IP~3~ from phosphatidyl inositol (PIP~2~) by phospholipase C (PLC). In the second term, v~5~ is the maximal rate of dephosphorylation of IP~3~ by a 5-phosphatase governed by the binding constant K~5~. The third term represents the rate of IP~3~ phosphorylation to inositol 1,3,4,5-tetrakisphosphate by a 3-kinase with maximal rate v~6~ and binding constant K~6~ that is increased by Ca^2+^ with binding constant K~7~ ([Figure 1](#fig1){ref-type="fig"}B) \[[@bib27]\]. The rate constants are defined as shown in [Table 1](#tbl1){ref-type="table"}.

The production dynamics for diacyl glycerol (DAG) is that same as IP~3~ as they are both produced by PLC. The dynamics equation of free cytosolic concentration of DAG is$$\frac{d\left\lbrack {DAG} \right\rbrack_{cyt}}{dt} = v_{4} - v_{8}\left\lbrack {DAG} \right\rbrack_{cyt}$$

The mitochondrial Ca^2+^ dynamics are governed by three processes: (1) Ca^2+^ influx through the Ca^2+^ uniporter (J~UNI~), (2) Ca^2+^ efflux through the Na^+^-Ca^2+^ exchanger (J~NCLX~) and (3) Ca^2+^ buffering \[[@bib80], [@bib81]\]. The Ca^2+^ influx through uniporter (J~UNI~) is described as by Nguyen and Jafri \[[@bib81]\] using on the Goldman-Hodgkin-Katz (GHK) equation as follows$$J_{UNI} = P_{UNI}\frac{z\Psi_{m}F}{V_{mito}RT}\frac{\alpha_{m}\left\lbrack Ca^{2 +} \right\rbrack_{m}\ \exp\left\lbrack \frac{- z\Psi_{m}F}{RT} \right\rbrack - \alpha_{SS}\left\lbrack Ca^{2 +} \right\rbrack_{ss}}{\exp\left\lbrack \frac{- z\Psi_{m}F}{RT} \right\rbrack - 1}$$where P~UNI~ is the permeability of the uniporter, z is the valence of Ca^2+^, Ψ~m~ is the mitochondrial membrane potential, F is Faraday\'s constant, V~mito~ is the mitochondrial matrix volume, R is the ideal gas constant, T is the absolute temperature, α~m~ and α~SS~ are the mitochondrial and subspace activity coefficients for Ca^2+^ at the mouth of the uniporter which is thought to be a channel. The Ca^2+^ efflux through the Na^+^-Ca^2+^ exchanger (J~NC~) used the formulation by Jafri and Nguyen \[[@bib81]\] described by$$J_{NC} = \frac{v_{NC}\left\lbrack {e^{0.5\Psi_{m}F/RT}\frac{\left\lbrack Na^{+} \right\rbrack_{ss}^{3}\left\lbrack Ca^{2 +} \right\rbrack_{m}}{K_{Na}^{3}K_{Ca}} - e^{- 0.5\Psi_{m}F/RT}\frac{\left\lbrack Na^{+} \right\rbrack_{m}^{3}\left\lbrack Ca^{2 +} \right\rbrack_{ss}}{K_{Na}^{3}K_{Ca}}} \right\rbrack}{1 + \frac{\left\lbrack Na^{+} \right\rbrack_{ss}^{3}}{K_{Na}^{3}} + \frac{\left\lbrack Ca^{2 +} \right\rbrack_{m}}{K_{Ca}} + \frac{\left\lbrack Na^{+} \right\rbrack_{ss}^{3}\left\lbrack Ca^{2 +} \right\rbrack_{m}}{K_{Na}^{3}K_{Ca}} + \frac{\left\lbrack Na^{+} \right\rbrack_{m}^{3}}{K_{Na}^{3}} + \frac{\left\lbrack Ca^{2 +} \right\rbrack_{ss}}{K_{Ca}} + \frac{\left\lbrack Na^{+} \right\rbrack_{m}^{3}\left\lbrack Ca^{2 +} \right\rbrack_{ss}}{K_{Na}^{3}K_{Ca}}}$$where K~Na~ is the Na^+^ binding constant, K~Ca~ is the Ca^2+^ binding constant, V~NC~ is the maximal exchanger velocity, \[Na^+^\]~ss~ is the subspace Na^+^ concentration, and \[Na^+^\]~m~ is the mitochondrial Na^+^ concentration ([Table 4](#tbl4){ref-type="table"}). These two fluxes comprise the balance equations for \[Ca^2+^\]~m~$$\frac{d\left\lbrack Ca^{2 +} \right\rbrack_{m}}{dt} = \beta_{Ca}\left( {J_{UNI} - J_{NC}} \right)$$where β~Ca~ is a constant describing Ca^2+^ buffers in the mitochondria.

Mitochondrial Ca^2+^ uptake dynamics and depletion of the endoplasmic reticulum (ER) trigger prolonged Ca^2+^ influx through CRAC channels \[[@bib9], [@bib10], [@bib26], [@bib33], [@bib74]\]. The Ca^2+^ influx through CRAC channels (J~CRAC~) can be described by contributions from three components STIM1, CRACR2A, calmodulin and ORAI1 \[[@bib82],[@bib83]\]. STIM1 oligomerizes to activate the channel when \[Ca^2+^\]~ER~ is depleted and can be described by the Hodgkin-Huxley formalism$$\frac{dact}{dt} = \frac{act_{\infty} - act}{\tau_{bb}}$$where *act* is the fraction of channels activated, τ~bb~ is the time constant, and the steady state probability of the activation gate is$$act_{\infty} = \frac{K_{act}^{4.7}}{K_{act}^{4.7} + \left\lbrack {Ca^{2 +}} \right\rbrack_{ER}^{4.7}}$$with K~act~ as the Ca^2+^ dissociation constant \[[@bib84], [@bib85]\]. CRAC2A binding to ORAI1 is required for proper Ca^2+^ signaling during T-cell activation \[[@bib83], [@bib86]\]. CRACR2A disassociates from the ORAI1 protein when it binds Ca^2+^ leading to inactivation of the channel \[[@bib87]\]. Binding of Ca^2+^/calmodulin to ORAI1 has also been shown to inactivate the channel Ca^2+^ bound \[[@bib56], [@bib57]\]. This inactivation process is described by$$\frac{dinact}{dt} = \frac{inact_{\infty} - inact}{\tau_{cc}}$$where *inact* is the fraction of channels activated. The time constant$$\tau_{cc} = \frac{200k_{cc}^{2}}{K_{cc}^{2} + \left\lbrack {Ca^{2 +}} \right\rbrack_{SS}^{2}}$$represents the inhibitory action of Ca^2+^/calmodulin with K~cc~ as the calcium binding affinity. The steady-state probability the inactivation gate$$inact_{\infty} = \frac{K_{inact}}{K_{inact} + \left\lbrack {Ca^{2 +}} \right\rbrack_{SS}}$$with K~inact~ as the dissociation constant for Ca^2+^ binding represents Ca^2+^ binding to CRACR2A. These are approximations as quantitative data is not yet available. The I~CRAC~ is based on the GHK equation and closely matches the experimental results shown by Bautista et. al., \[[@bib26]\], ([Figure 15](#fig15){ref-type="fig"}A).$$I_{CRAC} = P_{CRAC}\frac{z^{2}VF^{2}}{RT}\frac{\alpha_{SS}\left\lbrack Ca^{2 +} \right\rbrack_{ss}\ \exp\left\lbrack \frac{zVF}{RT} \right\rbrack - \alpha_{o}\left\lbrack Ca^{2 +} \right\rbrack_{o}}{\exp\left\lbrack \frac{zVF}{RT} \right\rbrack - 1}$$here P~CRAC~ is the permeability of Ca^2+^, V is the cell membrane potential, and α~o~ is the extracellular activity coefficient for Ca^2+^ at the mouth of the channel. In this context, α~SS~ is the subspace activity coefficient at the mouth of the I~CRAC~ channel. The rate constants are shown in [Table 5](#tbl5){ref-type="table"}. Finally, the Ca^2+^ is$$J_{CRAC} = \frac{I_{CRAC}}{2FV_{SS}} \times act \times inact$$where V~SS~ is subspace volume.Figure 15**Simulated I**~**CRAC**~**and J**~**PMCA**~**.** (A) Extracellular calcium concentration was set to 2.0 mM to measure I~CRAC~ from -100 mV to +50 mV. (B) J~PMCA~ as function of \[Ca^2+^\]~cyt~ is shown for two pump states, modulated and unmodulated.Figure 15

The final flux that influences the Ca^2+^ dynamics is the transfer from the subspace into the cytosol (J~SScyt~)$$J_{SScyt} = \frac{\left\lbrack Ca^{2 +} \right\rbrack_{SS} - \left\lbrack Ca^{2 +} \right\rbrack_{cyt}}{\tau_{SScyt}}$$where τ~sscyt~ is transfer time between the subspace and the cytosol. The subspace Ca^2+^ dynamics can be described in terms of the fluxes described above by$$\frac{d\left\lbrack Ca^{2 +} \right\rbrack_{SS}}{dt} = \beta_{ss}\left( {\frac{V_{mito}}{V_{SS}}\left( {J_{NC} - J_{UNI}} \right) + \frac{V_{cyt}}{V_{SS}}\left( {J_{CRAC} - J_{SScyt}} \right)} \right)$$where V~cyt~ is the cytosolic volume and the volume ratios rescale the fluxes to account for the volume difference between the subspace and the other compartments ([Table 6](#tbl6){ref-type="table"}). The factor β~ss~ represents the buffering in the subspace and is described by$$\beta_{ss} = \left\{ {1 + \frac{\left\lbrack B_{s} \right\rbrack_{ss}K_{s}^{cyt}}{\left. Ca^{2 +} \right\rbrack{\left\lbrack Ca^{2 +} \right\rbrack\left. \left\lbrack Ca^{2 +} \right\rbrack_{ss} \right)}^{2}} + \frac{\left\lbrack B_{e} \right\rbrack_{ss}K_{e}^{ss}}{\left. Ca^{2 +} \right\rbrack{\left\lbrack Ca^{2 +} \right\rbrack\left. \left\lbrack Ca^{2 +} \right\rbrack_{ss} \right)}^{2}}} \right\}^{- 1}$$

The total concentrations of stationary (s) and exogenous (e) buffers are represented by \[B~j~\]~SS~, and $K_{j}^{ss}$(*j = s,e*) are their dissociation constants for Ca^2+^ ([Table 3](#tbl3){ref-type="table"}).

According to Bautista and co-workers, the plasma-membrane Ca^2+^-ATPase (PMCA) controls a majority of the extrusion of Ca^2+^ and is slowly modulated by changes in calcium concentration \[[@bib26]\]. They observed altered Michaelis-Menten kinetics that describes Ca^2+^ removal in the modulated (pre-incubated with high Ca^2+^) and unmodulated states. A Hodgkin-Huxley type formalism is used here to describe transitions between the two states of PMCA designated U (unmodulated) and M (modulated) (M) PMCA. Transitions to and from the modulated state are represented by the rate constants w~1~ which depends upon \[Ca^2+^\]~cyt~ and w~2~,$$\text{U}\underset{w_{2}}{\overset{w_{1}}{\rightleftarrows}}\text{M}$$where$$w_{1}\left( Ca^{2 +} \right) = p_{1} \times \left\lbrack Ca^{2 +} \right\rbrack_{cyt}$$and $w_{2} = 0.01$, where p~1~ = 0.1 μM^−1^ is the rate constant for activation of the PMCA. These rate constants were estimated to match experimental results. The fraction of the pumps in the unmodulated state (u) can be described by$$\frac{du}{dt} = \frac{u_{\infty} - u}{\tau_{u}}$$where$$\tau_{u} = \frac{1}{w_{1}\left( Ca^{2 +} \right) + w_{2}}$$and$$u_{\infty} = \frac{w_{2}}{w_{1}\left( Ca^{2 +} \right) + w_{2}}$$

The total PMCA (plasma membrane Ca^2+^-ATPases) flux (J~PMCA~), including contributions from both the unmodulated and modulated states, is given by$$J_{PMCA} = \left( {u\frac{v_{u}\left\lbrack Ca^{2 +} \right\rbrack_{cyt}^{1.8}}{K_{u}^{1.8} + \left\lbrack Ca^{2 +} \right\rbrack_{cyt}^{1.8}} + m\frac{v_{m}\left\lbrack Ca^{2 +} \right\rbrack_{cyt}^{2.1}}{K_{m}^{2.1} + \left\lbrack Ca^{2 +} \right\rbrack_{cyt}^{2.1}}} \right)$$where m is the fraction of pumps in the modulated state (m + u = 1). The parameters v~u~ and v~m~ denote the maximal rate of unmodulated and modulated PMCA fluxes, and K~u~ and K~m~ are the \[Ca^2+^\]~cyt~ for half maximal velocity for V~u~ and V~m~, respectively. These parameters, including the exponents 1.8 and 2.1, are taken to fit the experimental data observed by Bautista and coworkers \[[@bib26]\]. [Figure 15](#fig15){ref-type="fig"}B shows the changes in J~PMCA~ as a function of \[Ca^2+^\]~cyt~ during unmodulated and modulated PMCA. PMCA efflux increases when \[Ca^2+^\]~cyt~ increases more in the modulated state ([Figure 15](#fig15){ref-type="fig"}B − red line) than in the unmodulated state ([Figure 15](#fig15){ref-type="fig"}B − blue line), which are fitted to experimental data of Bautista and co-workers \[[@bib26]\].

I~PMCA~ is the total PMCA current is given by$$I_{PMCA} = J_{PMCA}\left( {V_{cyt} \times z \times F \times 10^{6}} \right)$$

The balance equation for cytosolic calcium concentration is given by$$\frac{d\left\lbrack {Ca^{2 +}} \right\rbrack_{cyt}}{dt} = \beta_{cyt}\left( {J_{IP_{3}R} - J_{SERCA} - J_{PMCA} + J_{SScyt} + J_{CaL} + J_{TRPC3}} \right)$$using fluxes described above. In this equation, β~cyt~ is the cytosolic Ca^2+^ buffering factor,$$\beta_{cyt} = \left\{ {1 + \frac{\left\lbrack B_{s} \right\rbrack_{cyt}K_{s}^{cyt}}{\left( {K_{s}^{cyt} + \left\lbrack {Ca^{2 +}} \right\rbrack_{cyt}} \right)^{2}} + \frac{\left\lbrack B_{e} \right\rbrack_{cyt}K_{e}^{cyt}}{\left( {K_{e}^{cyt} + \left\lbrack {Ca^{2 +}} \right\rbrack_{cyt}} \right)^{2}}} \right\}^{- 1}$$with the total concentrations of stationary (s) and exogenous (e) buffers represented by \[B~j~\]~cyt~, and $K_{j}^{cyt}$(*j* = *s,e*) their dissociation constants for Ca^2+^. Note that the model assumes that the total buffer concentrations in the subspace and cytosol are equal ([Table 3](#tbl3){ref-type="table"}).

The equations of model I~K~ current are defined as follows$$I_{K} = G_{t} \times xn \times xj \times \left( V - E_{K} \right)$$the activation (xn) and inactivation (xj) gating variables are fitted to experimental data of Dupuis and co-workers \[[@bib28]\] as shown in [Figure 16](#fig16){ref-type="fig"} and described by the equations$$xn_{\infty} = \frac{1}{1 + e^{{(V + 11)}/ - 15.2}}$$$$xj_{\infty} = \frac{1}{1 + e^{{(V + 45)}/9}}$$$$\tau_{xn} = \frac{1}{\left( 0.2e^{0.032(V - 0.0677)} \right)}$$and$$\tau_{xj} = \frac{15}{0.03\left( e^{0.0083{(V + 40.8)}} + 0.4865e^{- 0.06{(V + 60.49)}} \right)}$$Figure 16Experimental (symbols) and model optimized (lines) I~K~ current. (A) I~K~ current activation and (B) inactivation curves. (C) n-gate and j-gate (D) time constants.Figure 16

The I~K(Ca)~ current can be described by$$I_{K{(Ca)}} = \frac{E_{\max}}{1 + \left( \frac{K_{d}}{\left\lbrack Ca^{2 +} \right\rbrack_{cyt}} \right)^{3}} \times \left( V - E_{K} \right)$$where E~max~ = 0.8 nS \[[@bib6]\] and K~d~ = 0.45 μM is derived from the experiments of Verheugen and co-workers \[[@bib29]\].

The model of the fast Na^+^ current include activation and inactivation gate is based on the Luo-Rudy model \[[@bib32]\]. The formulation is given by$$I_{Na} = G_{Na} \times m^{3} \times h \times j \times \left( V - E_{Na} \right)$$

Activation gate m and inactivation gate are described as

For V$\geq$-40 mV$$\alpha_{h} = \alpha_{j} = 0.0$$$$\beta_{h} = \frac{1}{0.13 \times \left( {1 + e^{(V + 10.66)/ - 11.1)}} \right)}$$and$$\beta_{j} = \frac{0.3 \times e^{({- 2.535 \times 10^{- 7}V})}}{1 + e^{( - 0.1(V + 32)}}$$

For V$<$-40 mV$$\alpha_{h} = 0.135 \times e^{({80 + \frac{V}{- 6.8}})}$$and$$\beta_{h} = 3.56 \times e^{({0.079V})} + 3.1 \times 10^{5} \times e^{0.35V}$$$$\alpha_{j} = \frac{- 1.2714 \times 10^{5} \times e^{0.244V} - 3.474 \times 10^{- 5} \times e^{- 0.04391V} \times \left( {V + 37.78} \right)}{1 + e^{0.311{({V + 79.23})}}}$$and$$\beta_{j} = \frac{0.1212 \times e^{({- 0.1052V})}}{1 + e^{( - 0.1378(V + 40.14)}}$$$$\alpha_{m} = \frac{0.32 \times \left( {\text{V} + 47.13} \right)}{1 - e^{( - 0.1(V + 47.13)}}$$and$$\beta_{m} = 0.08 \times e^{({- \frac{V}{11}})}$$

L-type voltage gates Ca^2+^ channels have been found in human T cells \[[@bib88]\]. The L-type calcium current also follows the formulation from the Luo-Rudy model given by$$I_{CaL} = \ dff_{Ca}\overline{I_{CaL}}$$where the maximal current $\overline{I_{CaL}}$, the activation gate d, and inactivation gate *f*, and Ca^2+^ inactivation gate *f*~Ca~ are described by$$\overline{I_{CaL}} = P_{CaL}zF\frac{z^{2}F^{2}}{RT}\frac{\propto_{cyt} - \propto_{o}}{e^{\frac{zVF}{RT}} - 1}$$$$f_{Ca} = \frac{1}{1 + \left( {\left\lbrack {Ca^{2 +}} \right\rbrack_{cyt}/0.6} \right)^{2}}$$$$d_{\infty} = \frac{1}{1 + e^{({- \frac{({V + 10})}{6.24}})}}$$$$f_{\infty} = \frac{1}{1 + e^{(\frac{({V + 35})}{8.6})} + 0.6/\left( {1 + e^{(\frac{({50 - V})}{20})}} \right)}$$$$\tau_{d} = \frac{d_{\infty}\left( {1 - e^{({- \frac{({V + 10})}{6.24}})}} \right)}{0.35\left( {V + 10} \right)}$$$$\tau_{f} = \frac{1}{0.0197e^{({- {({0.0337{({V + 10})}^{2}})} + 2})}}$$

The TRPM4 channel is a non-selective cation channel that is activated by calcium and membrane potential, For this model the formulation developed by Gaur and co-workers was used \[[@bib30]\]:$$I_{TRPM4} = g_{TRPM4}x_{Cai}x_{v}\left( {V - E_{TRPM4}} \right)$$$$\frac{dx_{Ca}}{dt} = \frac{x_{Ca\infty} - x_{Ca}}{\tau_{xCai}}$$$$x_{Ca\infty} = \frac{1}{1 + \left( \frac{\left\lbrack {Ca^{2 +}} \right\rbrack_{cyt}}{1.3} \right)^{- 1.1}}$$$$x_{v} = 0.05 + \frac{0.95}{1 + e^{- {({{({V + 40})}/15})}}}$$where E~TRPM4~ is the reversal potential, g~TRPM4~ is the conductance, and τ~xCa~ is the Hodgkin-Huxley time constant.

The TRPC3 channel conducts Ca^2+^ and is activated by diacyl glycerol (DAG) with a roughly linear I--V relation \[[@bib31]\].$$I_{TRPC3} = g_{TRPC3}\frac{\left\lbrack {DAG} \right\rbrack}{\left\lbrack {DAG} \right\rbrack + K_{DAG}}\left( {V - E_{Ca}} \right)$$where K~DAG~ is the activation constant for DAG binding to the channel.

The chloride current (I~Cl~) is described by$$I_{Cl} = g_{Cl}\left( {V - E_{Cl}} \right)$$where g~Cl~ is the Cl^−^ channel conductance and E~Cl~ is the reversal potential for Cl^−^.

The \[DAG\] is produced by phospholipase C from the cleavage of PIP~2~ and thus has the same production rate (v~4~) as IP~3~. It is assumed to decay with first order kinetics with rate constant v~DAGdeg~.$$\frac{d\left\lbrack {DAG} \right\rbrack}{dt} = v_{4} - v_{DAGdeg}\left\lbrack {DAG} \right\rbrack$$

The membrane potential equation is given by$$\frac{dV}{dt} = \frac{- 1}{C_{m}}\left( {I_{K} + I_{K{({Ca})}} + I_{Na} + I_{CRAC} + I_{pmca} + I_{CaL} + I_{TRPM4} + I_{TRPC3} + I_{Cl}} \right)$$where C~m~ is the membrane capacitance.

In the simulations used to study NFAT and NFκB activation, we incorporated the NFAT and NFκB activation pathways described by Fisher and co-workers \[[@bib63]\] into this cytosolic Ca^2+^ transients model. The NFAT model has a modification to activation of calmodulin by Ca^2+^ to represent the 2 high and 2 low affinity binding sites of calmodulin replacing the dependence on $\left\lbrack {Ca^{2 +}} \right\rbrack^{3}$in that model by the equation$$20.0\frac{\left\lbrack {Ca^{2 +}} \right\rbrack^{2}}{\left\lbrack {Ca^{2 +}} \right\rbrack^{2} + \left( {1.0\mu M} \right)^{2}}\frac{\left\lbrack {Ca^{2 +}} \right\rbrack^{2}}{\left\lbrack {Ca^{2 +}} \right\rbrack^{2} + \left( {10.0\mu M} \right)^{2}}$$

To study JNK activation, the cytosolic Ca^2+^ transients generated by this model were used as inputs for the model of JNK activation. Using the law of mass action, the reaction scheme in [Figure 9](#fig9){ref-type="fig"}A yields a system of 3 coupled first order differential equations.$${\frac{df_{JNK:Cn}}{dt} = k_{1}\left( 1 - f_{JNK:Cn} - f_{JNK:PKC} - f_{JNK:PKC:Cn} \right)\left\lbrack C \ast_{c} \right\rbrack - k_{2}f_{JNK:Cn}}{+ k_{8}f_{JNK:PKC:Cn} - k_{7}f_{JNK:Cn}\left\lbrack PKC\theta \ast \right\rbrack}$$$${\frac{df_{JNK:PKC}}{dt} = k_{3}\left( 1 - f_{JNK:Cn} - f_{JNK:PKC} - f_{JNK:PKC:Cn} \right)\left\lbrack PKC\theta \ast \right\rbrack - k_{4}f_{JNK:PKC}}{+ k_{6}f_{JNK:PKC:Cn} - k_{5}f_{JNK:PKC}\left\lbrack C \ast_{c} \right\rbrack}$$$$\frac{df_{JNK:PKC:Cn}}{dt} = k_{5}f_{JNK:PKC}\left\lbrack C \ast_{c} \right\rbrack - k_{6}f_{JNK:PKC:Cn} + k_{7}f_{JNK:Cn}\left\lbrack PKC\theta \ast \right\rbrack - k_{8}f_{JNK:PKC:Cn}$$

The model simulates the JNK activation pathways that are involved in the activation of transcription factor AP-1 in T lymphocytes. AP-1 binds to promoter regions of DNA with transcription factors NFAT and NFκB initiating new gene transcription results in cell proliferation and differentiation \[[@bib23]\].

Many studies have shown that PKCs and calcineurin act as co-activators of JNK leading to phosphorylation of c-Jun. [Figure 9](#fig9){ref-type="fig"}B shows that the percent active JNK in the cytoplasm falls rapidly when PKCθ concentrations are low, which agrees with the experimental results shown in Leung and co-workers \[[@bib44]\]. As in experiment, with activation the phosphorylated JNK reaches a maximum at about 30 min, declines to half maximum at about 45 min and is close to zero after 2 h.

Avraham and colleagues \[[@bib20]\] suggest that calcineurin and PKCθ must co-stimulate to reach full activation of JNK. A high calcineurin concentration does not activate JNK. On the other hand, high PKCθ concentration can induce about 50% JNK activation. [Figure 9](#fig9){ref-type="fig"}C shows that the fold activation only reached to 1 with calcineurin, and that fold activation is 8.7 with PKCθ, which matches with the experimental data shown \[[@bib20]\].

4.2. Sensitivity analysis {#sec4.2}
-------------------------

A sensitivity analysis was performed to demonstrate how NFAT activation depended upon model parameters ([Figure 14](#fig14){ref-type="fig"}). Sensitivity was calculated by:$$\frac{\ln\left( \frac{\text{fre.}\ \text{of}\ \text{UDB}\ \text{at}\  + 10\text{\%}}{\text{fre.}\ \text{of}\ \text{UDB}\ \text{at}\  - 10\text{\%}} \right)}{\ln\left( \frac{\text{rate}\ \text{at}\  + 10\text{\%}}{\text{rate}\ \text{at}\  - 10\text{\%}} \right)}$$

The parameters controlling CRAC current, K^+^ currents, and membrane potential show the greatest effect on active NFAT. Upon further exploration, the model suggests CRAC current is essential for the elevation in cytosolic Ca^2+^ sufficiently to activate NFAT. Hence increasing the Ca^2+^ entry via CRAC enhances NFAT activation. Reduction of the membrane potential serves to reduce CRAC current making it an important parameter. Therefore, K^+^ current that help to maintain the membrane potential by opposing depolarization by CRAC are necessary to maintain sufficient driving force for Ca^2+^ entry to activate NFAT. These studies suggest the important components for T cell activation.

4.3. Numerical methods {#sec4.3}
----------------------

The differential equations defining the model were solved using Euler\'s Method with a fixed time step of 0.01 s. The computer program was written in FORTRAN and run on Linux workstations. Numerical results were visualized using MATLAB 7.0.1 by The MathWorks, Inc.

Model parameters may be loosely divided into three groups: 1) derived from published data, 2) estimated from published data so that model variable value and time course conformed to experimental data, and 3) fitted specific model equations to experimental data.
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